Premodifier: clinical
Head noun: trial

Same concepts
http://dbpedia.org/resource/Clinical_trial

Broader concepts

labelprovenanceconfidence
research activityisap:2917067380.933079
research studyisap:3686869310.877869
research projectisap:2214112670.868903
general corporate purposeisap:2252310370.863075
research protocolisap:2954793930.861066
product candidateisap:3376726120.853592
thingisap:3704824550.852090
medical researchisap:2967944070.849706
research settingisap:2246656540.842986
development activityisap:2917067340.831007
product development activityisap:2917067410.829733
type of clinical researchisap:1945704700.828790
treatment optionisap:1596148160.826296
topicisap:3694765380.825745
translational researchisap:2967944220.825271
clinical research studyisap:3686869610.817677
development expenseisap:2283370940.816131
product developmentisap:2091314190.811993
activityisap:2917067360.799156
third partyisap:3704239090.796069
experimental studyisap:3686869640.788770
clinical research settingisap:2246656560.785079
research programisap:2215498610.784792
healthcare professionalisap:4274238010.776351
clinical applicationisap:2074217560.776296
product development programisap:2215498650.774311
clinical research activityisap:2917067450.772834
clinical research projectisap:2214112690.771124
information about brain tumorisap:2068822120.764727
drug development activityisap:2917067480.762088
clinical studyisap:3686869460.759823
timeisap:1946280010.754289
studyisap:3686869300.753192
human subject researchisap:2967944550.752610
original manuscriptisap:2579830260.746251
biomedical researchisap:2967944260.745018
intervention studyisap:3686870990.744480
research methodologyisap:2069922050.744442
therapeutic strategyisap:2963713340.743051
resourceisap:2964956980.742871
therapeutic approachisap:2955016060.741871
cancer-related topicisap:3694765440.741453
commercialization effortisap:1539902960.740601
clinical investigationisap:966221110.740073
patient-oriented researchisap:2967944140.738930
development workisap:1941255940.738510
approval procedureisap:3354616820.737373
drug candidateisap:3376726130.737308
controlled studyisap:3686869690.737024
relevant informationisap:2068822070.735401
additional informationisap:2068821990.735341
research purposeisap:2252310400.734542
scientific studyisap:3686869380.733748
type of researchisap:1945704710.733425
additional studyisap:3686869790.733246
primary studyisap:3686870900.733206
development programisap:2215498630.732583
research effortisap:1539902940.730687
development effortisap:1539902910.729031
scientific methodisap:1621073250.728942
other purposeisap:2252310390.727439
post-marketing studyisap:3686870640.725940
development costisap:1964749130.725301
interventional studyisap:3686869960.720280
aspect of drug developmentisap:1564309070.717031
design studyisap:3686869600.716203
scientific methodologyisap:2069922060.715130
research informationisap:2068822100.713787
study in humanisap:3686869920.713399
web siteisap:1945492030.712581
clinical researchisap:2967944040.711330
related topicisap:3694765430.711315
particular type of researchisap:1945704910.709843
medical developmentisap:2091314260.704327
other studyisap:3686869990.702252
serviceisap:2313926290.699314
experimentisap:2586399460.698260
example in biostatistic applicationisap:2298505370.690681
research initiativeisap:2582269770.690254
human subjectisap:2272591310.689184
applicationisap:2074217540.689089
form of clinical researchisap:1957906570.687892
analysis of experimental studyisap:2983653750.685287
treatment for pancreatic cancerisap:3349841670.683565
human studyisap:3686870000.681848
important milestoneisap:3366775650.680076
observational studyisap:3686869720.678487
scientific research studyisap:3686870400.677449
translational studyisap:3686871190.676112
further studyisap:3686869590.675575
medical issueisap:3727988330.675263
further investigationisap:966221100.670421
methodisap:1621073170.667841
optionisap:1596148150.662249
regulatory approvalisap:2954553320.660107
investigationisap:966221060.648832
efficacyisap:2956228680.646462
programisap:2215498620.643457
treatment approachisap:2955016050.640472
treatment of individualisap:3349841570.638937
publication typeisap:1945704800.634185
scientific evidenceisap:2972888700.634026
prospective studyisap:3686869660.632004
future product candidateisap:3376726160.628959
area of researchisap:1962224630.623996
failureisap:2252094960.622161
ethical issueisap:3727988240.622017
productisap:2224774770.621543
health-related researchisap:2967944420.619174
human researchisap:2967944480.617969
scientific investigationisap:966221080.616418
scientific processisap:2225847520.612920
other product candidateisap:3376726150.611628
datum from multiple sourceisap:3710842020.610633
pharmaceutical industryisap:2965603190.604649
type of studyisap:1945704730.604627
united statesisap:1558302460.603349
medical studyisap:3686869950.598404
organizationisap:4281439810.595266
development expenditureisap:2076592060.593315
public health sensitive issueisap:1569243320.593106
cochrane collaborationisap:970356050.591862
controlled settingisap:2246656570.589686
large studyisap:3686870240.589068
source of informationisap:1548843670.588126
strategyisap:2963713320.587686
projectisap:2214112680.586967
functionisap:2958350980.583273
type of informationisap:1945704920.580810
study designisap:1594711980.579816
pharmaceutical companyisap:2293353020.579781
type of projectisap:1945704840.577587
service researchisap:2967944510.577484
medical treatmentisap:3349841490.577319
conditionisap:3374648430.574188
developmentisap:2091314170.574079
formal evaluationisap:2599391500.573781
development processisap:2225847470.573746
other optionisap:1596148510.573620
oneisap:3261971240.570913
issue in clinical researchisap:3727988300.568601
fda approvalisap:2954553350.568196
systematic reviewisap:1585470340.564785
original researchisap:2967944180.564407
type of cancerisap:1945704850.564339
public useisap:3262172440.561114
trialisap:3695187250.560766
high riskisap:1944528530.558634
sourceisap:1548843660.558258
cooperative groupisap:3667389880.556988
future researchisap:2967944540.556304
processisap:2225847340.555823
matterisap:1598345280.555420
further testingisap:2238186270.555343
increase in activityisap:2978610820.555286
original studyisap:3686869560.553804
multiple dose studyisap:3686870600.553285
operationisap:3365838520.552852
stepisap:1944676800.552424
multi-site studyisap:3686871270.551432
technologyisap:2585314660.549560
areaisap:1962224610.548648
toolisap:1946482350.547136
questionisap:2938683210.546867
publicisap:1646015400.546080
treatment option forisap:1596148340.545783
research instituteisap:3365028510.543000
cost of developmentisap:1964749120.542906
good optionisap:1596148300.542512
clinical trialisap:3695187280.540892
part of the researchisap:1968402840.537322
available treatment optionisap:1596148380.533448
materialisap:2966065660.532661
new datumisap:3710842040.532377
further researchisap:2967944090.531807
researchisap:2967944030.531736
number of reportisap:1562639400.528365
opportunityisap:2084207720.527797
researcherisap:2588465770.526764
recordisap:1570084520.525887
outcomeisap:2279043040.524791
informationisap:2068821950.524195
workisap:1941255790.522946
initiativeisap:2582269780.521516
commercializationisap:2046141490.521477
effectivenessisap:967616010.518940
additionisap:2916977240.518077
regulatory authorityisap:3365526590.516263
datum sourceisap:1548843730.514256
advanceisap:2290708130.513263
discoveryisap:3358365480.513068
backgroundisap:2584714860.510406
partisap:1968402800.506031
important considerationisap:968900690.502019
latest treatmentisap:3349841590.500254
promising compoundisap:2977098610.499964
part of the drugisap:1968402990.497545
manufacturingisap:968994340.497409
costisap:1964749110.494023
issueisap:3727988100.492631
scienceisap:2276540730.492440
more researchisap:2967944150.491905
brainisap:3664600390.489237
newsisap:1967063230.489002
appropriateisap:2070220230.486645
protocolisap:2954793940.485185
peopleisap:1556553610.483981
medical deviceisap:1599477970.483975
facultyisap:2298834520.483851
partnershipisap:2086128150.482243
experimental treatmentisap:3349841780.481898
drugisap:1963814950.481215
termisap:1946084940.478479
practical matterisap:1598345590.476898
assistanceisap:2588211210.474747
type of research studyisap:1945704690.470976
drug studyisap:3686870750.470946
important factorisap:1554649470.469334
exampleisap:2298505280.469228
collaborationisap:970356030.466690
purposeisap:2252310380.465324
registryisap:2987662810.464394
effortisap:1539902900.464216
clinical datumisap:3710842030.463134
testingisap:2238186230.462157
institutionisap:2072399090.461926
randomizedisap:2602509870.460468
vaccineisap:2262148570.456491
group of patientisap:3667389830.453475
prospectiveisap:2073918720.452778
datum collectionisap:2596640200.452747
eventisap:3760909470.452735
careisap:1965282800.452576
gold standardisap:2931295580.451248
typeisap:1945704820.450358
laboratoryisap:2612932250.450001
phaseisap:3649731400.449679
expenseisap:2283370930.449238
meansisap:3755797000.448213
wayisap:3262128190.441644
linkisap:1973047720.441067
publicationisap:2085469870.440211
standardisap:2931295590.439468
option for patientisap:1596148190.438426
reviewisap:1585470390.436726
drug developmentisap:2091314200.435111
accessisap:1609266610.432499
cancer researchisap:2967944160.432307
complicationisap:4279399370.431682
nihisap:3261861300.430437
open-labelisap:2614372340.428349
health professionalisap:4274238020.428318
eye diseaseisap:2273400340.421209
companyisap:2293352980.414844
procedureisap:3354616810.414721
goalisap:1960925700.413061
new treatmentisap:3349841760.413051
studentisap:2305089030.411578
analysisisap:2983653690.410398
ccsviisap:3678407030.408321
relationshipisap:4281025160.407628
giftisap:1961286530.407340
familyisap:1561741870.406590
businessisap:2917905150.406480
last resortisap:1586775630.405208
test resultisap:1587573630.401768
variety of reasonisap:2232448570.399391
taskisap:1944815570.398529
designisap:1594712010.397508
side effectisap:1540254760.396062
subset of clinical researchisap:1562577700.394231
diagnosisisap:3385332730.392805
requirementisap:2068543280.392053
countryisap:2223970840.391769
resultisap:1587573600.390619
implementationisap:528308950.387868
aspectisap:1564309050.387632
indicationisap:2578263880.385743
somethingisap:3351822030.384136
priorityisap:2946760740.383957
stateisap:3685467220.382611
forefrontisap:3363905730.381668
formisap:1957906470.380269
step in the developmentisap:1944676830.374405
challengeisap:3351808620.374341
evaluationisap:2599391530.373979
furtherisap:2245238330.373533
impedimentisap:2579934630.364393
evidenceisap:2972888570.363581
u.sisap:3262119780.363526
controlisap:2264649940.363316
anythingisap:2948744160.362790
interestisap:2937814960.362231
step on the roadisap:1944676890.361520
regulatory environmentisap:2069423300.361284
for peopleisap:1556553620.357856
pilot studyisap:3686871030.357245
siteisap:1945492050.356932
step in the processisap:1944676970.356280
usisap:2395830190.352899
candidateisap:3376726140.351444
expectationisap:2065120160.351368
oxycodone matrix systemisap:1588316440.350598
interventionisap:4276401690.350435
providerisap:2930198850.350099
benefitisap:2217779410.348870
stem cellisap:1964674880.347882
statementisap:3376082830.346357
factorisap:1554649420.344268
part of the processisap:1968402880.343289
stuffisap:3686898020.342664
websiteisap:2222799730.341505
markerisap:1616761180.340639
diseaseisap:2273400230.339551
stisap:2395827630.339395
measureisap:2258181360.338622
doctorisap:1563327750.335922
development in the historyisap:2091314270.335194
important for peopleisap:1556553560.333660
tremendous benefitisap:2217779450.332889
industryisap:2965603180.332226
advancementisap:2086279270.330588
datumisap:3710841920.330480
trendisap:3695353610.330143
crucial componentisap:3394459550.329118
riskisap:1944528500.326474
pathisap:1968410050.325210
appropriate optionisap:1596148180.323287
targetisap:1633999290.323286
alternative for patientisap:2079384010.320811
important partisap:1968403000.320020
important stepisap:1944676950.320020
approachisap:2955016000.318813
groupisap:3667389840.318084
safetyisap:1531733720.313026
registrationisap:4272503720.312892
childisap:3698296650.311429
important optionisap:1596148280.310977
major focusisap:3699522810.310168
adverse eventisap:3760909390.305698
settingisap:2246656550.305518
immunotherapyisap:968313990.304154
stem cell therapyisap:2279793350.299025
bad ideaisap:1970237330.297920
stageisap:3685505050.297410
recommendationisap:522777380.297374
expensive processisap:2225847350.297113
gene therapyisap:2279793330.295742
good ideaisap:1970237290.292407
needisap:1967051100.290875
successisap:2291098310.289808
lymphomaisap:2981157940.289199
careerisap:1560673630.289054
phase iiisap:2395817710.288723
chanceisap:1560767040.287833
reasonisap:1572657150.286668
techniqueisap:3382862550.282916
sisap:522689380.281303
medicationisap:2587645840.281230
yearisap:1941690160.280503
cancerisap:1556962590.278855
elementisap:2236332670.278616
policyisap:1627715460.277824
therapyisap:2279793230.276320
experienceisap:2601275490.275209
biasisap:1961885660.271193
physicianisap:3391428380.271060
placeisap:3646511880.267612
of workisap:1941255900.267569
detailisap:1593306490.265793
testisap:1946086540.263929
marketingisap:3373552620.261549
psychotherapyisap:964624670.255050
cureisap:1964129620.250660
populationisap:2588985320.249821
lawisap:3261800710.249542
treatmentisap:3349841430.248646
thereforeisap:3393985570.243601
pointisap:3643444750.235427
summaryisap:2254365090.230291
componentisap:3394459510.226540
volunteerisap:3353965740.224752
attemptisap:2274461800.224178
possibilityisap:2073182800.222757
hospitalisap:2912623400.219200
guideisap:3668035450.216067
staffisap:3685506830.215188
notisap:3261871490.214719
pageisap:1968387580.210618
useisap:3262172410.210392
howeverisap:2232250270.209734
numberisap:1562639260.208759
conductisap:2279664520.205552
decisionisap:2960338690.204967
clinicisap:1592228440.202863
todayisap:3693732510.202332
factisap:1958535030.200452
minorityisap:2942752380.199658
best practiceisap:2973942620.198018
womanisap:3712917210.196139
tumorisap:3692043150.193399
aisap:522690970.190759
problemisap:2219912970.188492
placeboisap:2255575860.187161
understandingisap:964796220.186247
timingisap:1625923630.185189
chemotherapyisap:4276207550.168891
preventionisap:2607613630.167810
systemisap:1588316310.165705
futureisap:1545725930.165252
scientistisap:3369701890.153953
patientisap:2260798940.144354
geneisap:1961377390.138329
varietyisap:2232448610.138324
misap:522692330.137436

Narrower concepts

labelprovenanceconfidence
gene therapyisap:335107210.850899
randomize controlled trialisap:3695187750.789001
health initiativeisap:4733190800.751610
diabetes controlisap:383320340.749980
randomize trialisap:3695188710.749542
investigative siteisap:936403410.737379
phase 1isap:3738606790.707718
vaccine trialisap:3695187580.705464
patient screeningisap:134043220.703250
drug candidateisap:147457690.702615
limited toisap:4652166440.702346
diabetes prevention programisap:322013670.701037
car t cell trialisap:3695188040.690229
adverse eventisap:3654209580.689283
breast cancer prevention trialisap:3695187480.688066
investigator grantisap:3650858620.665132
african americanisap:3623795320.662911
united statesisap:1220638340.655603
prevention trialisap:3695187680.651132
tamoxifenisap:161042920.650975
clinical researchisap:3573262870.626090
phase iii clinical trialisap:3738606830.613999
laboratory workisap:899129490.609793
site selectionisap:131865120.605026
dose-ranging studyisap:3706999550.603975
studyisap:3706998740.602697
datum integrityisap:140439660.598876
drug trialisap:3695188050.598080
vitamin eisap:1314451670.596577
research coordinatorisap:4135024860.592229
phase iiiisap:4695701750.584332
size of the patientisap:883758350.575337
placebo controlisap:383320390.568972
phase 3 clinical trialisap:3738606860.562198
interestisap:3604341690.553618
raw datumisap:3647701550.553300
cardiovascular diseaseisap:370543210.548213
pancreatic cancerisap:1233649260.541370
healthy volunteerisap:172213530.541110
clinical trialisap:3695187280.540892
only optionisap:1237459650.539931
type 1 diabetesisap:952297080.538005
metastatic colorectal cancerisap:1233649230.533860
study designisap:1195588470.533697
number of patientisap:1192857670.531535
universityisap:4736336100.527293
side effectisap:1208191080.527207
safety datumisap:3647701470.525052
vitamin cisap:1317974490.522301
alzheimer diseaseisap:370543120.521782
pregnant womanisap:3700614020.518536
breast cancerisap:1233648960.514969
placebo-controlled studyisap:3706999500.513272
hormonal therapyisap:335107270.511493
cancer treatmentisap:158347320.511044
prostate cancerisap:1233649200.508091
benefitisap:331427320.502789
pain managementisap:4735663090.500728
cd4 countisap:3753130920.495707
chemotherapyisap:680571530.495073
starisap:889801720.490031
ukpdisap:943288780.480869
medical careisap:852407860.478517
groupisap:3650168870.471116
hypertensionisap:682398330.465395
phase iii trialisap:3738606780.461025
otherisap:3765384270.459785
eligibilityisap:4142104660.457194
new medicationisap:4765227450.455450
hyperlipidemiaisap:1314412390.449309
pharmaceutical industryisap:3615839650.447252
recruitmentisap:4152396120.446290
celiac diseaseisap:370543220.445840
phase 3 pivotal trialisap:3738607010.443070
blood pressureisap:3625276550.442629
phase 3isap:3738606890.441519
screeningisap:134043250.439665
enrollmentisap:4733811460.438168
recruitingisap:4729035770.433509
phase 3 studyisap:3738607030.433258
heart diseaseisap:370543140.431455
analysisisap:3594665610.430612
clinicianisap:160518000.429279
developmentisap:4157956790.428268
methodologyisap:4152765330.427538
phase iiisap:3738606910.421255
randomizedisap:4741141100.420976
phase 1 clinical trialisap:3738606920.414118
mitoxantroneisap:680404380.413149
clinical studyisap:3706999450.413107
preventionisap:4739535270.407142
cancerisap:1233648920.407127
protocolisap:3574678070.403199
feeisap:4702362670.403067
provisionisap:133988340.402855
topicisap:3744913780.400271
comparisonisap:4761440790.400111
registryisap:3608780370.391260
md andersonisap:3582138360.387254
projectisap:371834820.385329
participantisap:4139255620.383638
complianceisap:4740947860.383014
conductisap:355676440.382540
epidemiological studyisap:3707000400.379240
phase iii clinical studyisap:3738607070.377906
completionisap:4749983130.377019
altsisap:866561180.375905
dementiaisap:3626256460.373347
trialisap:3695187170.373100
pilotisap:3741945220.373059
hivisap:4687689790.368446
requirementisap:4140692810.363378
diabetesisap:3577700980.362684
maleisap:866047700.362211
safetyisap:1229661990.361915
activityisap:3638323040.356407
fdaisap:4691030990.355507
applicationisap:4138731240.350109
strokeisap:1195573890.347134
treatmentisap:158347240.345785
treatment regimenisap:338338190.341386
glaucomaisap:3604282280.340217
asiaisap:927996680.337096
governmentisap:4750193150.335437
research studyisap:3706999330.331851
aim-highisap:3577295010.331063
minority populationisap:4756205190.329990
resultisap:1240274550.323817
husbandisap:354233490.323562
indicationisap:4754238350.322888
new wayisap:4686337470.318247
phase 2isap:3738606820.316654
adultisap:3725663800.315335
diarrheaisap:3599811330.315071
lung cancerisap:1233648970.314710
testingisap:391066160.313670
new drugisap:851276360.313564
siteisap:936403400.313233
investigatorisap:677707680.308032
nihisap:4705450720.307448
hormoneisap:336348140.307379
oneisap:4672224740.306647
industryisap:3615839670.305474
chemoisap:3694768750.304441
drug companyisap:369413150.303505
riskisap:918837520.302959
womanisap:3700613960.300425
symptomisap:336163240.297064
abilityisap:378076200.295160
adolescentisap:4733622360.293613
manisap:4674760780.288873
vaccineisap:311462070.286599
measurementisap:4153671260.286013
geneisap:879582090.284866
inabilityisap:124418120.283461
brain tumorisap:3742203250.281126
agentisap:3765250030.279918
radiationisap:160890110.277296
childisap:3645120010.276710
costisap:895246110.276153
registrationisap:679144470.272812
eisap:1314451660.271816
howeverisap:352324120.271626
europeisap:1204409600.271300
productisap:365737400.271071
randomizationisap:1422393400.270503
monitoringisap:4752610230.270006
physicianisap:148579300.268700
phaseisap:3738606770.268281
respectisap:362428420.266065
bcptisap:892630040.265307
natureisap:1183936580.265143
theisap:4702718230.265031
bisap:1317453840.262710
ethicisap:3677822430.259421
informationisap:4136584740.259414
acupunctureisap:4134769400.258580
efficacyisap:3603824810.250657
disorderisap:3639523420.245151
new therapyisap:335107300.244739
diseaseisap:370543050.243106
lymphomaisap:3604176730.238713
immunotherapyisap:1422666310.238462
vaccinationisap:4135492210.238238
vomitingisap:3583322130.237665
subjectisap:313110020.233913
biologicisap:3612912570.233684
treatment optionisap:1237459620.231237
centreisap:1240637350.228291
testisap:907650930.227665
patientisap:323154530.226288
placeboisap:332248260.223675
malariaisap:366880840.216726
issueisap:3652928510.214865
qualityisap:358358430.213498
treatment for patientisap:158347270.212358
volunteerisap:172213500.211595
followisap:1228288450.210306
researchisap:3573262830.202071
countryisap:319684370.201161
reasonisap:1178501860.200694
meta-analysisisap:1418748340.200365
datumisap:3647701420.199655
cisap:1317974440.198932
needisap:855608590.198857
doctorisap:1188747620.198266
researcherisap:4760235640.197998
lifeisap:895682240.197156
eventisap:3654209560.197117
nauseaisap:1176116030.195168
practiceisap:3587705780.194590
questionisap:3593320030.189650
associationisap:4157395560.187557
typeisap:952297070.184185
foodisap:947929410.183830
factisap:914527210.183780
drugisap:851276330.182535
breastisap:1174747650.180026
interventionisap:678335580.178460
hopeisap:938255580.174209
methodisap:1134943770.170534
therapyisap:335107220.170419
statisticsisap:4749243200.161511
similarlyisap:135817970.158550
germanyisap:374127390.158398
psychotherapyisap:1420058760.154557
formulumisap:3585216860.150890
minorityisap:3615867720.145972
schizophreniaisap:1424614630.140452
peopleisap:1146846660.135327
populationisap:4756205140.133919
leukemiaisap:3620807320.129867
wayisap:4686337460.126222
accuracyisap:3606094240.122772
somethingisap:147806810.121268
labisap:4680059210.119787
exerciseisap:3597346430.119495
fundingisap:328403800.102022
outcomeisap:381243960.086799
controlisap:383320360.078675
medicineisap:3609770910.072379
doseisap:949138800.057732
oisap:1311282860.023624